NewGenIvf (NIVF) Return on Sales (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Return on Sales of 0.05% for Q4 2025, down 5.0% year-over-year from 0.06% in Q4 2024, and down 141.48% quarter-over-quarter from 0.13% in Q3 2025.
NewGenIvf (NIVF) Return on Sales (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported Return on Sales for 2 consecutive years, with 0.05% the latest figure, recorded in Q4 2025.
- In Q4 2025, Return on Sales fell 5.0% year-over-year to 0.05%; the TTM figure through Dec 2025 stood at 0.02% (changed N/A YoY), while the FY2025 annual figure was 0.02%, up 2.0% from the prior year.
- Return on Sales fell to 0.05% in Q4 2025 per NIVF's latest filing, from 0.13% in the prior quarter.
- Across five years, Return on Sales topped out at 0.13% in Q3 2025 and bottomed at 0.05% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 88.19 Bn | 90.61 Bn | 15.19 Bn | 0.00% |
| 2 | Tenet Healthcare | 21.59 Bn | 21.56 Bn | 4.45 Bn | 0.00% |
| 3 | Encompass Health | 12.19 Bn | 12.86 Bn | 1.34 Bn | 0.00% |
| 4 | Davita | 11.52 Bn | 12.39 Bn | 1.16 Bn | 0.00% |
| 5 | Ensign | 10.59 Bn | 10.27 Bn | 306.24 Mn | 0.00% |
| 6 | Universal Health Services | 8.79 Bn | 8.72 Bn | 3.29 Bn | 0.00% |
| 7 | Pacs | 7.04 Bn | 6.88 Bn | 338.46 Mn | 0.00% |
| 8 | Chemed | 6.96 Bn | 6.92 Bn | 221.47 Mn | 0.00% |
| 9 | Concentra Group Holdings Parent | 4.52 Bn | 4.38 Bn | 192.10 Mn | 0.00% |
| 10 | NewGenIvf | 9,048.24 | -1.43 Mn | 524,025.00 | -0.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.05% |
| Sep 30, 2025 | 0.13% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |